What are CCR3 antagonist drugs?

CCR3 antagonist drugs are pharmacologic agents that share a common mechanism (typically targeting CCR3 (C-C chemokine receptor type 3)). 0 are currently marketed, with 3 more in clinical development.

CCR3 antagonist

0 marketed 3 in Phase 3

This page covers all CCR3 antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CCR3 (C-C chemokine receptor type 3), CCR3.

Targets

CCR3 (C-C chemokine receptor type 3) · CCR3

Phase 3 pipeline (3)

SB213503 lot 2 · GlaxoSmithKline · Respiratory / Immunology
SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases.
SB213503 lot 3 · GlaxoSmithKline · Respiratory/Immunology
SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases.
SB213503 lot 1 · GlaxoSmithKline · Respiratory / Immunology
SB213503 is a selective antagonist of the chemokine receptor CCR3, which blocks eosinophil recruitment and activation in inflammatory airway diseases.